Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	22773
Country	Türkiye

Received	2015-09-22 08:24
Peer-Review Started	2015-10-03 20:55
To Make the First Decision	2015-11-06 10:55
Return for Revision	2015-11-06 11:28
Revised	2016-01-24 08:09
Second Decision	2016-02-16 13:51
Accepted by Journal Editor-in-Chief	2016-02-16 14:19
Accepted by Company Editor-in-Chief	2016-02-24 14:31
Articles in Press	2016-02-24 14:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-13 14:43
Publish the Manuscript Online	2016-05-10 08:16

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Current adjuvant treatment modalities for gastric cancer: From history to the future
Manuscript Source	Invited Manuscript
All Author List	Leyla Kilic, Cetin Ordu, Ibrahim Yildiz, Fatma Sen, Serkan Keskin, Rumeysa Ciftci and Kezban Nur Pilanci
Funding Agency and Grant Number
Corresponding Author	Cetin Ordu, MD, Department of Medical Oncology, Istanbul Bilim University, Büyükdere Cad. No.120, Şişli, Istanbul 34394, Turkey. cetinordu@hotmail.com
Key Words	Adjuvant chemoradiotherapy; Biomarker; Gastric cancer; Lymph nodes
Core Tip	Despite extensive surgery, gastric cancer will likely recur for most patients. Fortunately, additional treatment modalities either in the perioperative or post-operative setting provide varying degrees of survival advantage. Although there is considerable data regarding adjuvant chemotherapy and chemora-diotherapy since the Intergroup-0116 study, there is still no established uniform treatment protocol depending on the type of surgery, histological subgroup, or extent of disease. The present review is aimed at identifying the advances in treatment strategies and discussing the pros and cons of each strategy.
Publish Date	2016-05-10 08:16
Citation	Kilic L, Ordu C, Yildiz I, Sen F, Keskin S, Ciftci R, Pilanci KN. Current adjuvant treatment modalities for gastric cancer: From history to the future. World J Gastrointest Oncol 2016; 8(5): 439-449
URL	http://www.wjgnet.com/1948-5204/full/v8/i5/439.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i5.439

Full Article (PDF)	WJGO-8-439.pdf
Full Article (Word)	WJGO-8-439.doc
Manuscript File	22773-Review.doc
Answering Reviewers	22773-Answering reviewers.pdf
Audio Core Tip	22773-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	22773-Conflict-of-interest statement.pdf
Copyright License Agreement	22773-Copyright assignment.pdf
Institutional Animal Care and Use Committee Approval Form or Document	Institutional_Animal_Care_and_Use_Committee_Statement_20150922005748.docx
Non-Native Speakers of English Editing Certificate	22773-Language certificate.pdf
Peer-review Report	22773-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	22773-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	22773-Scientific misconduct check.pdf
Scientific Editor Work List	22773-Scientific editor work list.pdf